ANIX logo

ANIX
Anixa Biosciences Inc

10,497
Mkt Cap
$85.5M
Volume
70,023.00
52W High
$5.46
52W Low
$2.33
PE Ratio
-8.10
ANIX Fundamentals
Price
$2.55
Prev Close
$2.72
Open
$2.69
50D MA
$2.88
Beta
1.14
Avg. Volume
104,062.09
EPS (Annual)
-$0.3367
P/B
5.66
Rev/Employee
$0.00
$117.85
Loading...
Loading...
News
all
press releases
Anixa Biosciences (NASDAQ:ANIX) Stock Rating Lowered by Wall Street Zen
Wall Street Zen lowered Anixa Biosciences from a "hold" rating to a "sell" rating in a research report on Saturday...
MarketBeat·2d ago
News Placeholder
More News
News Placeholder
Anixa Biosciences Advances Breast Cancer Vaccine Toward Phase 2 After Positive Phase 1 Results; Cytovance Selected for cGMP Manufacturing
Anixa Biosciences Advances Breast Cancer Vaccine Toward Phase 2 After Positive Phase 1 Results; Cytovance Selected for cGMP Manufacturing Anixa Biosciences Advances Breast Cancer Vaccine Toward Phase...
PR Newswire·5d ago
News Placeholder
Anixa Biosciences (NASDAQ:ANIX) Given Buy Rating at D. Boral Capital
D. Boral Capital reissued a "buy" rating and set a $10.00 target price on shares of Anixa Biosciences in a report on Tuesday...
MarketBeat·6d ago
News Placeholder
Anixa Biosciences Announces Presentation of its Ovarian Cancer CAR-T Therapy Clinical Trial at the Society of Gynecologic Oncology Annual Meeting on Women's Cancer
Anixa Biosciences Announces Presentation of its Ovarian Cancer CAR-T Therapy Clinical Trial at the Society of Gynecologic Oncology Annual Meeting on Women's Cancer Anixa Biosciences Announces...
PR Newswire·7d ago
News Placeholder
Anixa Biosciences (NASDAQ:ANIX) Stock Rating Upgraded by Wall Street Zen
Wall Street Zen raised shares of Anixa Biosciences from a "sell" rating to a "hold" rating in a research note on Monday...
MarketBeat·14d ago
News Placeholder
Anixa Biosciences (NASDAQ:ANIX) Lowered to "Sell" Rating by Wall Street Zen
Wall Street Zen lowered shares of Anixa Biosciences from a "hold" rating to a "sell" rating in a research report on Sunday...
MarketBeat·22d ago
News Placeholder
Anixa Biosciences AGM: Shareholders Back Directors as CEO Highlights CAR-T, Vaccine Progress
Anixa Biosciences (NASDAQ:ANIX) held its 2026 Annual Meeting of Stockholders via live webcast, outlining the results of shareholder votes and providing an operational update focused on the company's...
MarketBeat·23d ago
News Placeholder
Anixa Biosciences Featured on Water Tower Research Healthcare Happenings Podcast
Anixa Biosciences Featured on Water Tower Research Healthcare Happenings Podcast Anixa Biosciences Featured on Water Tower Research Healthcare Happenings Podcast PR Newswire SAN JOSE, Calif., March...
PR Newswire·25d ago
News Placeholder
Anixa Biosciences (NASDAQ:ANIX) Posts Earnings Results, Beats Expectations By $0.01 EPS
Anixa Biosciences (NASDAQ:ANIX - Get Free Report) posted its quarterly earnings data on Monday. The company reported ($0.08) EPS for the quarter, topping the consensus estimate of ($0.09) by $0.01...
MarketBeat·27d ago
News Placeholder
Anixa Biosciences Receives Notice of Allowance from Korean Ministry of Intellectual Property (MOIP) for Patent Covering Breast Cancer Vaccine Technology
Anixa Biosciences Receives Notice of Allowance from Korean Ministry of Intellectual Property (MOIP) for Patent Covering Breast Cancer Vaccine Technology Anixa Biosciences Receives Notice of Allowance...
PR Newswire·28d ago
<
1
2
...
>

Latest ANIX News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.